Alnylam Pharmaceuticals | ALNY - Receita De Vendas

Preço das Ações
313.78
Mudança Diária
-1.02 -0.32%
Mensal
-6.67%
Anual
23.76%
Q1 Previsão
303.95




Vendas Alterar Data
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amgen USD 9.9B 340M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Incyte USD 1.51B 140M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Moderna USD 678M 342M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 14.36B 478M 2025-09
PTC Therapeutics USD 164.7M 46.3M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 12.2B 3.19B 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Xencor USD 28.24M 7.24M 2025-12